UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to Section 240.14a-12

THE FEMALE HEALTH COMPANY

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials:
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


  *** Exercise Your Right to Vote ***   
 

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on March 16, 2017

 

   LOGO
                 
        Meeting Information        
  THE FEMALE HEALTH COMPANY      

 

Meeting Type: Annual Meeting

       
        For holders as of: January 13, 2017        
        Date: March 16, 2017            Time: 2:00 PM EDT        
 

LOGO

 

     

Location:  Greenberg Traurig, LLP

                  333 SE 2nd Avenue

                  44th Floor

                  Miami, Florida 33131

       
                 
             

LOGO

    

 

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

  
        See the reverse side of this notice to obtain proxy materials and voting instructions.   
       

 

    

  
  

Broadridge Internal Use Only

 

Job #

Envelope #

Sequence #

# of # Sequence #


— Before You Vote —

How to Access the Proxy Materials

 

    

 

Proxy Materials Available to VIEW or RECEIVE:

      
    

 

1. Notice & Proxy Statement        2. Annual Report

 

How to View Online:

 

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

 

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

1) BY INTERNET:          www.proxyvote.com

2) BY TELEPHONE:     1-800-579-1639

3) BY E-MAIL*:             sendmaterial@proxyvote.com

 

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before March 02, 2017 to facilitate timely delivery.

 

      
           
           
           
           
           
           
           
           
         
    

 

— How To Vote —

Please Choose One of the Following Voting Methods

 

    
LOGO          

 

 

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

      
           
           
           
           
             
             Internal Use  Only
           
             
         


    Voting items        

LOGO

 

        The Board of Directors recommends you vote

        FOR the following:

     
 

 

       1.

 

 

 Election of Directors

         
   

 

 Nominees

     
 

 

       01

 

 

 David R. Bethune

   02   Mario Eisenberger   03   Harry Fisch   04   Mary Margaret Frank     05   Lucy Lu  
         06    Georges Makhoul    07   O.B. Parrish   08   Elgar Peerschke    09   Jesus Socorro     10   Mitchell S. Steiner  
 

 

       The Board of Directors recommends you vote FOR proposals 2 and 3.

 
 

 

       2

 

 

To ratify the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2017.

 
 

 

       3

 

 

To approve a non-binding advisory proposal on executive compensation.

 
 

 

       The Board of Directors recommends you vote 3 YEARS on the following proposal:

 
 

 

       4

 

 

To approve a non-binding advisory proposal on the frequency of future advisory votes on executive compensation.

 
 

 

       NOTE: In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the meeting.

 
             
             
             
             
             

 

LOGO

 

  

LOGO

      
       

Broadridge Internal Use Only

xxxxxxxxxx

xxxxxxxxxx

Cusip

Job  #

Envelope  #

Sequence  #

# of # Sequence #

 
         
         
         
           


  Reserved for Broadridge Internal Control Information                    
               
               
               
               
                 

 

 

 

NAME

  
 

THE COMPANY NAME INC. - COMMON

   123,456,789,012.12345                
 

THE COMPANY NAME INC. - CLASS A

   123,456,789,012.12345
 

THE COMPANY NAME INC. - CLASS B

   123,456,789,012.12345
 

THE COMPANY NAME INC. - CLASS C

   123,456,789,012.12345
 

THE COMPANY NAME INC. - CLASS D

   123,456,789,012.12345
 

THE COMPANY NAME INC. - CLASS E

   123,456,789,012.12345
 

THE COMPANY NAME INC. - CLASS F

   123,456,789,012.12345
 

THE COMPANY NAME INC. - 401 K

 

  

123,456,789,012.12345

 

   
   

 

 

 

LOGO

                  
                  
                  
                  
                  
                  
               

 

Broadridge Internal Use Only

       

THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE

 

 

Job #

Envelope #

Sequence #

# of # Sequence #